Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Therapie
|
December 13, 2021
From cardio-oncology to cardio-onco-pharmacology: Towards a multidisciplinary approach in the understanding and management of cardiotoxicity
Stéphane Ederhy, Perrine Devos, Ariel Cohen, et al.
Bulletin Du Cancer
|
August 23, 2017
[What biomarkers for the future? The point of view of the residents in oncology after the ESMO 2016 Congress]
Marie Auvray, Marc-Antoine Benderra, Marie Bretagne, et al.
Archives of Cardiovascular Diseases
|
January 1, 2025
Abatacept dose-finding phase II triaL for immune checkpoint inhibitors myocarditis (ACHLYS) trial design
Joe-Elie Salem, Stephane Ederhy, Lisa Belin, et al.
Clinical Genitourinary Cancer
|
May 16, 2022
Preexisting Autoantibodies and Immune Related Adverse Events in Metastatic Urothelial Carcinoma Patients Treated by Pembrolizumab
Zahra Castel-Ajgal, Claire Goulvestre, Sonia Zaibet, et al.
Frontiers in Cardiovascular Medicine
|
March 3, 2025
Case Report: Immune checkpoint-inhibitor related myotoxicity monitoring using a comprehensive cardiothoracic MRI approach: insights from a clinical case
Samia Boussouar, Etienne Charpentier, Baptiste Abbar, et al.
Archives of Cardiovascular Diseases
|
September 4, 2019
Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
Joe-Elie Salem, Marie Bretagne, Benedicte Lebrun-Vignes, et al.
Clinical Medicine (London, England)
|
August 3, 2021
Impact of the COVID-19 pandemic on the management of cancer patients: the experience of the cancer outpatients department of a university hospital in Paris
Camille Tlemsani, Jennifer Arrondeau, Sixtine De Percin, et al.
Archives of Cardiovascular Diseases
|
November 6, 2019
Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study
Marie Bretagne, Bénédicte Lebrun-Vignes, Antoine Pariente, et al.
Bulletin Du Cancer
|
February 3, 2016
[Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management]
Marie Bretagne, Pascaline Boudou-Rouquette, Olivier Huillard, et al.
Oncotarget
|
March 7, 2018
Dimethyl fumarate is highly cytotoxic in KRAS mutated cancer cells but spares non-tumorigenic cells
Nathaniel Edward Bennett Saidu, Marie Bretagne, Audrey Lupo Mansuet, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Therapie
|
December 13, 2021
From cardio-oncology to cardio-onco-pharmacology: Towards a multidisciplinary approach in the understanding and management of cardiotoxicity
Stéphane Ederhy, Perrine Devos, Ariel Cohen, et al.
Bulletin Du Cancer
|
August 23, 2017
[What biomarkers for the future? The point of view of the residents in oncology after the ESMO 2016 Congress]
Marie Auvray, Marc-Antoine Benderra, Marie Bretagne, et al.
Archives of Cardiovascular Diseases
|
January 1, 2025
Abatacept dose-finding phase II triaL for immune checkpoint inhibitors myocarditis (ACHLYS) trial design
Joe-Elie Salem, Stephane Ederhy, Lisa Belin, et al.
Clinical Genitourinary Cancer
|
May 16, 2022
Preexisting Autoantibodies and Immune Related Adverse Events in Metastatic Urothelial Carcinoma Patients Treated by Pembrolizumab
Zahra Castel-Ajgal, Claire Goulvestre, Sonia Zaibet, et al.
Frontiers in Cardiovascular Medicine
|
March 3, 2025
Case Report: Immune checkpoint-inhibitor related myotoxicity monitoring using a comprehensive cardiothoracic MRI approach: insights from a clinical case
Samia Boussouar, Etienne Charpentier, Baptiste Abbar, et al.
Archives of Cardiovascular Diseases
|
September 4, 2019
Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
Joe-Elie Salem, Marie Bretagne, Benedicte Lebrun-Vignes, et al.
Clinical Medicine (London, England)
|
August 3, 2021
Impact of the COVID-19 pandemic on the management of cancer patients: the experience of the cancer outpatients department of a university hospital in Paris
Camille Tlemsani, Jennifer Arrondeau, Sixtine De Percin, et al.
Archives of Cardiovascular Diseases
|
November 6, 2019
Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study
Marie Bretagne, Bénédicte Lebrun-Vignes, Antoine Pariente, et al.
Bulletin Du Cancer
|
February 3, 2016
[Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management]
Marie Bretagne, Pascaline Boudou-Rouquette, Olivier Huillard, et al.
Oncotarget
|
March 7, 2018
Dimethyl fumarate is highly cytotoxic in KRAS mutated cancer cells but spares non-tumorigenic cells
Nathaniel Edward Bennett Saidu, Marie Bretagne, Audrey Lupo Mansuet, et al.
Page
of 2